1
|
Wu W, Mu Y. Microfluidic technologies for advanced antimicrobial susceptibility testing. BIOMICROFLUIDICS 2024; 18:031504. [PMID: 38855477 PMCID: PMC11162290 DOI: 10.1063/5.0190112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/03/2023] [Accepted: 05/23/2024] [Indexed: 06/11/2024]
Abstract
Antimicrobial resistance is getting serious and becoming a threat to public health worldwide. The improper and excessive use of antibiotics is responsible for this situation. The standard methods used in clinical laboratories, to diagnose bacterial infections, identify pathogens, and determine susceptibility profiles, are time-consuming and labor-intensive, leaving the empirical antimicrobial therapy as the only option for the first treatment. To prevent the situation from getting worse, evidence-based therapy should be given. The choosing of effective drugs requires powerful diagnostic tools to provide comprehensive information on infections. Recent progress in microfluidics is pushing infection diagnosis and antimicrobial susceptibility testing (AST) to be faster and easier. This review summarizes the recent development in microfluidic assays for rapid identification and AST in bacterial infections. Finally, we discuss the perspective of microfluidic-AST to develop the next-generation infection diagnosis technologies.
Collapse
Affiliation(s)
- Wenshuai Wu
- Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing 210009, China
| | - Ying Mu
- Author to whom correspondence should be addressed:
| |
Collapse
|
2
|
Chen L, Zhu M, Wang Z, Wang H, Cheng Y, Zhang Z, Qi X, Shao Y, Zhang X, Wang H. A capillary-based centrifugal indicator equipped with in situ pathogenic bacteria culture for fast antimicrobial susceptibility testing. Analyst 2024; 149:2420-2427. [PMID: 38488061 DOI: 10.1039/d3an02144k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/16/2024]
Abstract
Antimicrobial resistance has become a major global health threat due to the misuse and overuse of antibiotics. Rapid, affordable, and high-efficiency antimicrobial susceptibility testing (AST) is among the effective means to solve this problem. Herein, we developed a capillary-based centrifugal indicator (CBCI) equipped with an in situ culture of pathogenic bacteria for fast AST. The bacterial incubation and growth were performed by macro-incubation, which seamlessly integrated the capillary indicator. Through simple centrifugation, all the bacterial cells were confined at the nanoliter-level capillary column. The packed capillary column height could linearly reflect the bacterial count, and the minimum inhibitory concentration (MIC) was determined based on the difference in the column height between the drug-added groups and the control group. The AST results could easily be determined by the naked eye or smartphone imaging. Thus, the CBCI realized the combination of macro-bacterial incubation and early micro assessment, which accelerated the phenotypic AST without complex microscopic counting or fluorescent labelling. The whole operation process was simple and easy to use. AST results could be determined for E. coli ATCC strains within 3.5 h, and the output results for clinical samples were consistent with the hospital reports. We expect this AST platform to become a useful tool in limiting antimicrobial resistance, especially in remote/resource-limited areas or in underdeveloped countries.
Collapse
Affiliation(s)
- Longyu Chen
- Institute of Eco-Environmental Forensics, School of Environmental Science and Engineering, Shandong University (Qingdao), Qingdao, Shandong, 266237, China.
| | - Meijia Zhu
- Institute of Eco-Environmental Forensics, School of Environmental Science and Engineering, Shandong University (Qingdao), Qingdao, Shandong, 266237, China.
| | - Zhiyong Wang
- China Academy of Building Research, Beijing, 100013, China
| | | | - Yongqiang Cheng
- Institute of Eco-Environmental Forensics, School of Environmental Science and Engineering, Shandong University (Qingdao), Qingdao, Shandong, 266237, China.
| | - Ziwei Zhang
- Institute of Eco-Environmental Forensics, School of Environmental Science and Engineering, Shandong University (Qingdao), Qingdao, Shandong, 266237, China.
| | - Xiaoxiao Qi
- Institute of Eco-Environmental Forensics, School of Environmental Science and Engineering, Shandong University (Qingdao), Qingdao, Shandong, 266237, China.
| | - Yifan Shao
- Institute of Eco-Environmental Forensics, School of Environmental Science and Engineering, Shandong University (Qingdao), Qingdao, Shandong, 266237, China.
| | - Xi Zhang
- Institute of Eco-Environmental Forensics, School of Environmental Science and Engineering, Shandong University (Qingdao), Qingdao, Shandong, 266237, China.
| | - Hongwei Wang
- Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China
| |
Collapse
|
3
|
Needs SH, Pivetal J, Hayward J, Kidd SP, Lam H, Diep T, Gill K, Woodward M, Reis NM, Edwards AD. Moving microcapillary antibiotic susceptibility testing (mcAST) towards the clinic: unravelling kinetics of detection of uropathogenic E. coli, mass-manufacturing and usability for detection of urinary tract infections in human urine. SENSORS & DIAGNOSTICS 2023; 2:736-750. [PMID: 37216011 PMCID: PMC10197089 DOI: 10.1039/d2sd00138a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/08/2022] [Accepted: 04/20/2023] [Indexed: 05/24/2023]
Abstract
Innovation in infection based point-of-care (PoC) diagnostics is vital to avoid unnecessary use of antibiotics and the development of antimicrobial resistance. Several groups including our research team have in recent years successfully miniaturised phenotypic antibiotic susceptibility tests (AST) of isolated bacterial strains, providing validation that miniaturised AST can match conventional microbiological methods. Some studies have also shown the feasibility of direct testing (without isolation or purification), specifically for urinary tract infections, paving the way for direct microfluidic AST systems at PoC. As rate of bacteria growth is intrinsically linked to the temperature of incubation, transferring miniaturised AST nearer the patient requires building new capabilities in terms of temperature control at PoC, furthermore widespread clinical use will require mass-manufacturing of microfluidic test strips and direct testing of urine samples. This study shows for the first-time application of microcapillary antibiotic susceptibility testing (mcAST) directly from clinical samples, using minimal equipment and simple liquid handling, and with kinetics of growth recorded using a smartphone camera. A complete PoC-mcAST system was presented and tested using 12 clinical samples sent to a clinical laboratory for microbiological analysis. The test showed 100% accuracy for determining bacteria in urine above the clinical threshold (5 out of 12 positive) and achieved 95% categorical agreement for 5 positive urines tested with 4 antibiotics (nitrofurantoin, ciprofloxacin, trimethoprim and cephalexin) within 6 h compared to the reference standard overnight AST method. A kinetic model is presented for metabolization of resazurin, demonstrating kinetics of degradation of resazurin in microcapillaries follow those observed for a microtiter plate, with time for AST dependent on the initial CFU ml-1 of uropathogenic bacteria in the urine sample. In addition, we show for the first time that use of air-drying for mass-manufacturing and deposition of AST reagents within the inner surface of mcAST strips matches results obtained with standard AST methods. These results take mcAST a step closer to clinical application, for example as PoC support for antibiotic prescription decisions within a day.
Collapse
Affiliation(s)
- Sarah H Needs
- Reading School of Pharmacy, University of Reading Whiteknights Campus Reading RG6 6AD UK +44(0)7906014116 +44(0)118 378 4253
| | - Jeremy Pivetal
- Reading School of Pharmacy, University of Reading Whiteknights Campus Reading RG6 6AD UK +44(0)7906014116 +44(0)118 378 4253
| | - Jessica Hayward
- Reading School of Pharmacy, University of Reading Whiteknights Campus Reading RG6 6AD UK +44(0)7906014116 +44(0)118 378 4253
| | - Stephen P Kidd
- Hampshire Hospitals NHS Foundation Trust Basingstoke and North Hampshire Hospital Basingstoke RG24 9NA UK
| | - HoYin Lam
- Hampshire Hospitals NHS Foundation Trust Basingstoke and North Hampshire Hospital Basingstoke RG24 9NA UK
| | - Tai Diep
- Reading School of Pharmacy, University of Reading Whiteknights Campus Reading RG6 6AD UK +44(0)7906014116 +44(0)118 378 4253
| | - Kiran Gill
- Reading School of Pharmacy, University of Reading Whiteknights Campus Reading RG6 6AD UK +44(0)7906014116 +44(0)118 378 4253
| | - Martin Woodward
- Department of Food and Nutrition Sciences, University of Reading Whiteknights Campus Reading RG6 6DX UK
| | - Nuno M Reis
- Department of Chemical Engineering and Centre for Biosensors, Biodevices and Bioelectronics (C3Bio), University of Bath Claverton Down Bath BA2 7AY UK +44(0)1225 383 369
- Capillary Film Technology (CFT) Daux Road Billingshurst RH14 9SJ UK
| | - Alexander D Edwards
- Reading School of Pharmacy, University of Reading Whiteknights Campus Reading RG6 6AD UK +44(0)7906014116 +44(0)118 378 4253
- Capillary Film Technology (CFT) Daux Road Billingshurst RH14 9SJ UK
| |
Collapse
|
4
|
Oeschger T, Kret L, Erickson D. Multiplexed paper-based assay for personalized antimicrobial susceptibility profiling of Carbapenem-resistant Enterobacterales performed in a rechargeable coffee mug. Sci Rep 2022; 12:11990. [PMID: 35835831 PMCID: PMC9283407 DOI: 10.1038/s41598-022-16275-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2022] [Accepted: 07/07/2022] [Indexed: 11/27/2022] Open
Abstract
The increasing prevalence of antibiotic resistance threatens to make currently treatable bacterial diseases deadly again. As drug resistance rises, antibiotic susceptibility testing needs to adapt to allow for widespread, individualized testing. Paper-based diagnostics offer low-cost, disposable alternatives to traditional time consuming and costly in-house methods. Here, we describe a paper-based microfluidic device, called the Bac-PAC, capable of categorizing the antibiotic susceptibly of individual strains of Carbapenem-resistant Enterobacterales. Each chip provides a colored readout with actionable susceptibility classification of three antibiotics, thus maximizing the chances of identifying a viable therapy. We verified the technology on thirty bacterial strains with two dyes using six clinically relevant antibiotics. We demonstrated that the dried tests are stable for one month and can be incubated in a rechargeable coffee mug that reduces the need for external infrastructure.
Collapse
Affiliation(s)
- Taylor Oeschger
- Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA
| | - Lauren Kret
- Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA
| | - David Erickson
- Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY, 14853, USA.
- Division of Nutritional Science, Cornell University, Ithaca, NY, 14853, USA.
| |
Collapse
|
5
|
Oeschger TM, McCloskey DS, Buchmann RM, Choubal AM, Boza JM, Mehta S, Erickson D. Early Warning Diagnostics for Emerging Infectious Diseases in Developing into Late-Stage Pandemics. Acc Chem Res 2021; 54:3656-3666. [PMID: 34524795 DOI: 10.1021/acs.accounts.1c00383] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
The spread of infectious diseases due to travel and trade can be seen throughout history, whether from early settlers or traveling businessmen. Increased globalization has allowed infectious diseases to quickly spread to different parts of the world and cause widespread infection. Posthoc analysis of more recent outbreaks-SARS, MERS, swine flu, and COVID-19-has demonstrated that the causative viruses were circulating through populations for days or weeks before they were first detected, allowing disease to spread before quarantines, contact tracing, and travel restrictions could be implemented. Earlier detection of future novel pathogens could decrease the time before countermeasures are enacted. In this Account, we examined a variety of novel technologies from the past 10 years that may allow for earlier detection of infectious diseases. We have arranged these technologies chronologically from pre-human predictive technologies to population-level screening tools. The earliest detection methods utilize artificial intelligence to analyze factors such as climate variation and zoonotic spillover as well as specific species and geographies to identify where the infection risk is high. Artificial intelligence can also be used to monitor health records, social media, and various publicly available data to identify disease outbreaks faster than traditional epidemiology. Secondary to predictive measures is monitoring infection in specific sentinel animal species, where domestic animals or wildlife are indicators of potential disease hotspots. These hotspots inform public health officials about geographic areas where infection risk in humans is high. Further along the timeline, once the disease has begun to infect humans, wastewater epidemiology can be used for unbiased sampling of large populations. This method has already been shown to precede spikes in COVID-19 diagnoses by 1 to 2 weeks. As total infections increase in humans, bioaerosol sampling in high-traffic areas can be used for disease monitoring, such as within an airport. Finally, as disease spreads more quickly between humans, rapid diagnostic technologies such as lateral flow assays and nucleic acid amplification become very important. Minimally invasive point-of-care methods can allow for quick adoption and use within a population. These individual diagnostic methods then transfer to higher-throughput methods for more intensive population screening as an infection spreads. There are many promising early warning technologies being developed. However, no single technology listed herein will prevent every future outbreak. A combination of technologies from across our infection timeline would offer the most benefit in preventing future widespread disease outbreaks and pandemics.
Collapse
Affiliation(s)
| | | | | | | | | | - Saurabh Mehta
- Department of Population Health Sciences, Weill Cornell Medicine, New York, New York 10065, United States
| | | |
Collapse
|
6
|
Oeschger TM, Erickson DC. Visible colorimetric growth indicators of Neisseria gonorrhoeae for low-cost diagnostic applications. PLoS One 2021; 16:e0252961. [PMID: 34138928 PMCID: PMC8211239 DOI: 10.1371/journal.pone.0252961] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 05/25/2021] [Indexed: 12/02/2022] Open
Abstract
N. gonorrhoeae is one of the most pressing antibiotic resistant threats of our time and low-cost diagnostics that can easily identify antibiotic resistance are desperately needed. However, N. gonorrhoeae responds so uniquely to growth conditions that it cannot be assumed gonorrhea will respond to common microbiological methods used for other pathogenic organisms. In this paper, we explore visual colorimetric indicators of N. gonorrhoeae growth that can be seen without a microscope or spectrophotometer. We evaluate growth media, pH indicators, resazurin-based dyes, and tetrazolium-based dyes for their use in simple colorimetric system. Overall, we identified Graver Wade media as the best at supporting robust gonococcal growth while also providing the least background when analyzing results of colorimetric tests. XTT, a tetrazolium-based dye, proved to show to brightest color change over time and not negatively impact the natural growth of N. gonorrhoeae. However, other dyes including PrestoBlue, MTT, and NBT are less expensive than XTT and work well when added after bacterial growth has already occurred. By identifying the specific use cases of these dyes, this research lays the groundwork for future development of a color-based antibiotic susceptibility low-cost test for N. gonorrhoeae.
Collapse
Affiliation(s)
- Taylor Mae Oeschger
- Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, United States of America
| | - David Carl Erickson
- Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, United States of America
- Division of Nutritional Science, Cornell University, Ithaca, New York, United States of America
- * E-mail:
| |
Collapse
|